IDAEO知識庫km.idaeo.ai

本文屬於主題館「牙醫」 → ← 回正文：補骨粉會有後遺症嗎？失敗了會怎樣？

補骨粉會有後遺症嗎？失敗了會怎樣？｜證據鏈

補骨粉會有後遺症嗎？失敗了會怎樣？｜證據鏈

AI 編輯（TK.Lin Agent）閱讀約 26 分鐘
#證據鏈#牙醫KM#台灣#補骨

本頁是〈補骨粉會有後遺症嗎？失敗了會怎樣？〉的事實單元帳：每一條主張對應的來源、證據等級、地域與期間、原文引句與限制，逐條攤開。

##事實（事實單元帳）

  • F1｜confidence: verified｜basis: peer_reviewed（PMID 28938030）｜period: 檢索至 2015-07，2018 刊出｜geo: universal｜span: 「The weighted complication rate of the overall soft tissue complications … was 16.8% (95% CI = 10.6% to 25.4%)」「soft tissue lesions were reported as early as 1 week and as late as 6 months」｜caveat: 為 GBR 軟組織併發症加權率，非個人風險
  • F2｜confidence: verified｜basis: peer_reviewed（PMID 35048503）｜period: 檢索至 2020-11，2022 刊出｜geo: universal｜span: 「incidence proportion of healing complications … 11.0%」「membrane exposure without suppuration, membrane exposure with suppuration, and with abscess formation … 8.7% … 0.7% … 0.5%」「RoM of vertical bone gained was 0.65 … and 0.62」「The RoM of vertical bone gained was 0.65 [95% CI = 0.47, 0.91] and 0.62 [95% CI = 0.45, 0.85] when membrane exposure without suppuration and abscess formation without membrane exposure occurred respectively, in comparison to uneventful healing.」「The site-level incidence proportion of membrane exposure without suppuration, membrane exposure with suppuration, and with abscess formation without membrane exposure was 8.7% [95% CI = 4.2, 14.2], 0.7% [95% CI = 0.0, 2.9], and 0.5% [95% CI = 0.0, 1.7], respectively.」｜caveat: 限垂直 GBR，位點層級
  • F3｜confidence: verified｜basis: peer_reviewed（PMID 30667522）｜period: 2019 刊出｜geo: universal｜span: 「complications rate of 47.3% for distraction osteogenesis, 4.18 mm and 12.1% for guided bone regeneration (GBR), and 3.46 mm and 23.9% for bone blocks」「although complications are common」｜caveat: 垂直骨增量情境
  • F4｜confidence: verified｜basis: peer_reviewed（PMID 35737681）｜period: 檢索 1960-01 至 2021-06｜geo: universal｜span: 「Postoperative pain, swelling, and edema were widely reported」「sinus membrane perforation (SMP), wound dehiscence, graft exposure and failure, and sinusitis」「benign paroxysmal positional vertigo following TSFE was significant in certain selected studies」｜caveat: 74 篇、4,411 例上顎竇增高術
  • F5｜confidence: verified｜basis: peer_reviewed（PMID 34250560）｜period: 2008 至 2020-04 文獻｜geo: universal｜span: 「survival rate of 97.68% … 98.88%」「The rate of Schneiderian membrane perforation … was 30.6%」「is not a risk factor for dental implant survival (p=0.229; …)」「A total of 1115 implants were placed under previously perforated and repaired membranes, obtaining a survival rate of 97.68%, while 2495 implants were placed below sinus membranes that were not damaged during surgery, obtaining a survival rate of 98.88%.」｜caveat: 限側窗術式、修補後
  • F6｜confidence: verified｜basis: peer_reviewed（PMID 37752820）｜period: 2023 刊出｜geo: universal｜span: 「regeneration occurred in a predictable way」「several complications (including exposure, infection, and soft tissue dehiscence) were reported, which tend to be higher when using cross-linked collagen membranes」｜caveat: 網絡統合分析，限同期植體置入之 GBR
  • F7｜confidence: verified｜basis: peer_reviewed（PMID 29231263）｜period: 2018 刊出｜geo: universal｜span: 「moderate limitation in the 1st 48 hr post-surgery but little or none by day 3 or 4」「Mild to moderate pain and interference to daily activities were reported for the first 3 days requiring the use of NSAIDs only」「mild to moderate pain and restrictions to daily activities for 48-72 hr」「morbidity were greater with autogenous bone harvesting」｜caveat: 60 人前瞻性對照試驗，上顎竇側窗術式；個別差異大
  • F8｜confidence: verified｜basis: peer_reviewed（PMID 35056347）｜period: 2021 刊出，292 篇納入｜geo: universal｜span: 「implants in smokers had a higher failure risk in comparison with non-smokers (OR 2.402, p < 0.001)」「MBL mean difference (MD) between the groups was 0.580 mm」｜caveat: 觀察性證據合併，非因果推論
  • F9｜confidence: verified｜basis: peer_reviewed（PMID 28332067）｜period: 2017 刊出｜geo: universal｜span: 「Postoperative infection and implant loss occurred in 8/121 sinuses (6.6%)」「Infection had the strongest correlation to preoperative chronic sinusitis (p = 0.007)」｜caveat: 單中心回溯，109 人
  • F10｜confidence: verified｜basis: peer_reviewed（PMID 36807599）｜period: 檢索至 2022-08｜geo: universal｜span: 「diabetic patients with dental implants and good glycaemic control have a significantly lower risk of peri-implantitis (odds ratio [OR] = 0.16」「risk of dental implant failure (or = 3.76; 95% ci: 1.50-9.45; …) appears to be greater under irregular or no SPC」｜caveat: 間接證據，作者標註證據侷限
  • F11｜confidence: verified｜basis: clinical_guideline（PMID 35300956，AAOMS 2022 立場書）｜period: 2022 更新版｜geo: universal｜span: 「Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaws (MRONJ)」｜caveat: 本文僅引用其存在與適用族群，不引用個別處置建議
  • F12｜confidence: verified｜basis: peer_reviewed（PMID 35472121）｜period: 2022 刊出｜geo: universal｜span: 「a protocol specific to the classification and management of d-PTFE membrane healing complications is required and is thus presented in this paper」｜caveat: 限 d-PTFE 膜材，說明「暴露需專業分類處置」而非自行處理
  • F13｜confidence: verified｜basis: peer_reviewed（PMID 37109671）｜period: 2023 刊出，12 篇 RCT｜geo: universal｜span: 「The routine use of prophylactic antibiotics to prevent infection in dental implant placement was found to be not sufficiently effective to justify routine use」「Clear clinical assessment pathways … are required」｜caveat: 屬臨床決策層面，病人不得據此自行停藥
  • F14｜confidence: verified｜basis: peer_reviewed（PMID 30155575）｜period: 2019 刊出｜geo: universal｜span: 「The interruption of antithrombotics prior to tooth removal because of the fear of bleeding or following postoperative bleeding increases the risk of thromboembolic events」「The investigated haemostatics included gauze pressure」｜caveat: 原研究情境為拔牙，本文僅引用止血措施類別與停藥風險
  • F15｜confidence: verified｜basis: peer_reviewed（PMID 34074573）｜period: 1997 至 2013 全國登錄，2022 刊出｜geo: universal｜span: 「other implant-related complications (infection, implant malposition, lack of bone at implant site, mechanical damage, or failed osseointegration)」｜caveat: 芬蘭理賠登錄資料，僅用於「神經損傷屬已知併發症類別」
  • F16｜confidence: verified（2026-08-05 複驗，同 #9 卡錨 C2）｜basis: law｜period: 現行條文｜geo: TW｜span: 《全民健康保險法》第 51 條「十一、義齒、義眼、眼鏡、助聽器、輪椅、拐杖及其他非具積極治療性之裝具。」｜caveat: 個別給付以健保署現行公告為準，本文不作給付判定
  • F17｜confidence: verified（2026-08-05）｜basis: law｜period: 現行條文｜geo: TW｜span: 《醫療法》第 63 條「醫療機構實施手術，應向病人或其法定代理人、配偶、親屬或關係人說明手術原因、手術成功率或可能發生之併發症及危險，並經其同意，簽具手術同意書及麻醉同意書，始得為之。」｜caveat: 條文引述，非法律意見
  • F18｜confidence: verified（2026-08-05）｜basis: law｜period: 現行條文｜geo: TW｜span: 《醫療法》第 81 條「醫療機構診治病人時，應向病人或其法定代理人、配偶、親屬或關係人告知其病情、治療方針、處置、用藥、預後情形及可能之不良反應。」｜caveat: 條文引述，非法律意見
  • F19｜confidence: verified（2026-08-05）｜basis: official_statement｜period: 資料集現況｜geo: TW｜span: 政府資料開放平臺資料集「臺北市醫療收費標準」，提供機關臺北市政府衛生局｜caveat: 單一縣市例證；其他縣市頁面放量前逐一補驗；同 #9 卡錨 C3 家族
  • F20｜confidence: verified（入口可及，2026-08-05 複驗 200）｜basis: official_statement｜period: 入口現況｜geo: TW｜span: 健保署醫材比價網入口 info.nhi.gov.tw/INAE2000/INAE2010S01｜caveat: 頁面內容為 JS 動態載入，curl 無法逐字比對，名稱與收錄範圍依 #9 卡錨 C4 查證；骨移植材料是否在可查品項，發布前補實測；2026-08-05 OP 實測更正：該網兩軌類別皆不含牙科，骨移植材料無法由此查證
  • F21｜confidence: verified｜basis: internal_data｜period: 2025-03 至 2026-08 GSC｜geo: TW｜span: backlog #28「補骨粉後遺症」等 7 詞項合計曝光 121,073，跨 4 站｜caveat: 曝光為屬性級數字，非去重流量
  • F22｜confidence: 結構性整理（編輯框架，非外部事實宣稱）｜basis: editorial_framework｜period: 2026-08-05｜geo: universal｜span: 「文獻中廣泛報告的反應／該安排回診／該盡快就醫」三級分辨框架與「一天比一天輕」的走勢判斷，為本站依 F1 至 F15 文獻整理的溝通用架構｜caveat: 非診斷工具，不取代臨床判斷
本文閱讀地圖；各項依正文順序排列:事實（事實單元帳）; 內部引用鏈
整理自原文；請配合正文閱讀

來源清單

取用日期均為 2026-08-05；PubMed 條目以 E-utilities efetch 取得摘要原文，並逐條實測條目頁回應 200。

  1. Lim G, et al. Wound Healing Complications Following Guided Bone Regeneration for Ridge Augmentation: A Systematic Review and Meta-Analysis. Int J Oral Maxillofac Implants. 2018;33(1):41-50. PMID 28938030
  2. Tay JRH, et al. Healing complications and their detrimental effects on bone gain in vertical-guided bone regeneration: A systematic review and meta-analysis. Clin Implant Dent Relat Res. 2022;24(1):43-71. PMID 35048503
  3. Urban IA, et al. Effectiveness of vertical ridge augmentation interventions: A systematic review and meta-analysis. J Clin Periodontol. 2019;46 Suppl 21:319-339. PMID 30667522
  4. Hsu YT, et al. Complications of sinus floor elevation procedure and management strategies: A systematic review. Clin Implant Dent Relat Res. 2022;24(6):740-765. PMID 35737681
  5. Díaz-Olivares LA, et al. Management of Schneiderian membrane perforations during maxillary sinus floor augmentation with lateral approach in relation to subsequent implant survival rates: a systematic review and meta-analysis. Int J Implant Dent. 2021;7(1):91. PMID 34250560
  6. Calciolari E, et al. Efficacy of biomaterials for lateral bone augmentation performed with guided bone regeneration. A network meta-analysis. Periodontol 2000. 2023;93(1):77-106. PMID 37752820
  7. Alayan J, Ivanovski S. A prospective controlled trial comparing xenograft/autogenous bone and collagen-stabilized xenograft for maxillary sinus augmentation. Clin Oral Implants Res. 2018;29(2):248-262. PMID 29231263
  8. Mustapha AD, et al. Smoking and Dental Implants: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021;58(1):39. PMID 35056347
  9. Kozuma A, et al. Preoperative chronic sinusitis as significant cause of postoperative infection and implant loss after sinus augmentation from a lateral approach. Oral Maxillofac Surg. 2017;21(2):193-200. PMID 28332067
  10. Carra MC, et al. Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis. J Clin Periodontol. 2023;50 Suppl 26:77-112. PMID 36807599
  11. Ruggiero SL, et al. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. J Oral Maxillofac Surg. 2022;80(5):920-943. PMID 35300956
  12. Vroom MG, et al. Clinical Classification of Healing Complications and Management in Guided Bone Regeneration Procedures with a Nonresorbable d-PTFE Membrane. Int J Periodontics Restorative Dent. 2022;42(3):419-427. PMID 35472121
  13. Torof E, et al. Antibiotic Use in Dental Implant Procedures: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2023;59(4):713. PMID 37109671
  14. Ockerman A, et al. Local haemostatic measures after tooth removal in patients on antithrombotic therapy: a systematic review. Clin Oral Investig. 2019;23(4):1695-1708. PMID 30155575
  15. Pääsky E, et al. Are women more susceptible than men to iatrogenic inferior alveolar nerve injury in dental implant surgery? Int J Oral Maxillofac Surg. 2022;51(2):251-256. PMID 34074573
  16. 全民健康保險法 第 51 條（全國法規資料庫）
  17. 醫療法 第 63 條（全國法規資料庫）
  18. 醫療法 第 81 條（全國法規資料庫）
  19. 政府資料開放平臺：臺北市醫療收費標準（提供機關：臺北市政府衛生局）
  20. 衛生福利部中央健康保險署 醫材比價網（入口）
  21. 內部數據：`analysis/reports/km-dental-backlog.md` #28 附錄（詞×站×曝光逐筆可對帳）
  22. 編輯框架：本站三級分辨結構（無外部來源，標示為結構性整理）

內部引用鏈

  • 費用怎麼問、報價單怎麼讀：植牙一顆到底多少錢？
  • 「牙套」名稱分流與費用組成：「牙套」要多少錢？

FAQ

什麼情況要盡快就醫，不能等？
化膿或形成膿瘍、明顯感染徵象、腫脹或疼痛不減反增、出血持續且加壓後仍難以控制，或嘴唇、下巴或舌頭持續麻木時，請盡快就醫 [F2][F6][F7][F22][F14][F15]。
骨粉「跑出來」是不是代表失敗了？
**不必然。** 顆粒外露多與傷口裂開或覆蓋膜暴露相關，系統性回顧把移植材料外露列為需要介入處理的併發症之一 [F4]，而膜暴露有專門的分類與處置流程，由醫師依材質與程度判斷 [F12]。文獻顯示併發症會讓骨增量減少（均值比 0.65 與 0.62）[F2]，但這與「整個療程作廢」是兩件事；請回診讓醫師評估，不要自行拔除外露物。
腫脹要多久才會消？
**依文獻描述的一般時程，頭 48 小時較明顯，術後第 3 至 4 天多降為輕微或沒有影響。** 前瞻性對照試驗記錄的是術後 48 至 72 小時的輕到中度疼痛與活動限制 [F7]。實際恢復速度因人而異，須由牙醫師評估。

來源錨定

引用本文

Lucy・《補骨粉會有後遺症嗎？失敗了會怎樣？｜證據鏈》・IDAEO 知識庫・2026-08-13・https://km.idaeo.ai/post/reports/dental-bone-graft-complications-evidence

更新於 2026-08-27

相關文章

更新 2026-08-27T05:11:19.384Z · server-rendered · four-language · IDAEO 知識庫